SEI
SEI Medical Public Company Limited engages in the distribution of scientific and medical equipment in Thailand. The company offers endoscopy, surgical, aesthetic, neonatal care, and laboratory equipment. It is also involved in the service and medical equipment lease contract businesses. The company was founded in 1986 and is based in Bangkok, Thailand.
SEI (SEI) - Net Assets
Latest net assets as of September 2024: ฿268.77 Million THB
Based on the latest financial reports, SEI (SEI) has net assets worth ฿268.77 Million THB as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿477.58 Million) and total liabilities (฿208.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿268.77 Million |
| % of Total Assets | 56.28% |
| Annual Growth Rate | 179.55% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SEI - Net Assets Trend (2022–2023)
This chart illustrates how SEI's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SEI (2022–2023)
The table below shows the annual net assets of SEI from 2022 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | ฿79.23 Million | +179.35% |
| 2022-12-31 | ฿28.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SEI's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 20.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿17.38 Million | 21.94% |
| Other Components | ฿61.85 Million | 78.06% |
| Total Equity | ฿79.23 Million | 100.00% |
SEI Competitors by Market Cap
The table below lists competitors of SEI ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Absolicon Solar Collector AB Series B
ST:ABSL-B
|
$3.29 Million |
|
Orex Minerals Inc
OTCQB:ORMNF
|
$3.29 Million |
|
Greenyield Bhd
KLSE:0136
|
$3.29 Million |
|
Brüder Mannesmann Aktiengesellschaft
F:BMM
|
$3.29 Million |
|
Truong Long Engineering and Auto JSC
VN:HTL
|
$3.29 Million |
|
PT Dewi Shri Farmindo Tbk
JK:DEWI
|
$3.28 Million |
|
BioNexus Gene Lab Corp Common stock
NASDAQ:BGLC
|
$3.28 Million |
|
Carmat
PA:ALCAR
|
$3.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SEI's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 28,362,725 to 79,231,409, a change of 50,868,684 (179.4%).
- Net income of 21,870,684 contributed positively to equity growth.
- Dividend payments of 75,002,000 reduced retained earnings.
- New share issuances of 54,000,000 increased equity.
- Other factors increased equity by 50,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿21.87 Million | +27.6% |
| Dividends Paid | ฿75.00 Million | -94.66% |
| Share Issuances | ฿54.00 Million | +68.15% |
| Other Changes | ฿50.00 Million | +63.11% |
| Total Change | ฿- | 179.35% |
Book Value vs Market Value Analysis
This analysis compares SEI's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.89x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 13.67x to 4.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ฿0.17 | ฿2.28 | x |
| 2023-12-31 | ฿0.47 | ฿2.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SEI utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 27.60%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.56%
- • Asset Turnover: 1.30x
- • Equity Multiplier: 3.82x
- Recent ROE (27.60%) is below the historical average (45.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 62.98% | 5.57% | 1.15x | 9.85x | ฿15.03 Million |
| 2023 | 27.60% | 5.56% | 1.30x | 3.82x | ฿13.95 Million |
Industry Comparison
This section compares SEI's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $93,798,890
- Average return on equity (ROE) among peers: 30.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SEI (SEI) | ฿268.77 Million | 62.98% | 0.78x | $3.29 Million |
| E for L Aim Public Company Limited (EFORL) | $-104.57 Million | 0.00% | 0.00x | $13.47 Million |
| Healthlead Public Company Limited (HL) | $124.97 Million | 41.67% | 2.19x | $14.11 Million |
| SaintMed Public Company Limited (SMD) | $135.64 Million | 40.21% | 2.49x | $11.69 Million |
| Techno Medical Public Company Limited (TM) | $222.40 Million | 20.33% | 1.97x | $2.99 Million |
| Winnergy Medical Public Company Limited (WINMED) | $90.56 Million | 49.99% | 2.66x | $3.06 Million |